European Pregnancy and Pediatric HIV Cohort Collaboration (EPPICC) study assessing the safety and efficacy of Kaletra oral solution in children aged 14 days to 2 years with HIV-1 infection in Europe First published 02/06/2020 Last updated 12/12/2024 EU PAS number:EUPAS32607 Study Finalised